Protein kinase C isoform (PKC isoform (PKCs for plural/family); individual examples include PKC alpha (PKCα), PKC beta (PKCβ), PKC gamma (PKCγ), etc.)

Protein kinase C isoforms are a family of serine/threonine protein kinases critical for transducing intracellular signals in response to external stimuli and play pivotal roles in controlling cellular proliferation, apoptosis, differentiation, and other key processes[3][6]. The family is subdivided into three groups based on their activation requirements: - **Conventional PKCs (cPKC)**: include alpha, beta I, beta II, and gamma; require calcium ions, diacylglycerol (DAG), and phospholipid for activation[1][6]. - **Novel PKCs (nPKC)**: include delta, epsilon, eta, and theta; require DAG but not calcium[1][3][6]. - **Atypical PKCs (aPKC)**: include zeta and iota/lambda; these are independent of both calcium and DAG[1][6]. These isoforms participate in the regulation of numerous cellular events, such as proliferation, apoptosis, autophagy, immune function, and differentiation[2][4][6]. They are implicated in various diseases—most notably in oncology, immunology, and neurobiology—and serve as both potential therapeutic targets and disease biomarkers. However, the multifaceted and isoform-specific nature of PKC function brings notable drug development challenges and safety considerations[2][6].

Other names

PKCProtein kinase C familyPKCαPKCβPKCγPKCδPKCεPKCζPKCηPKCθPKCιPKCλ

Inhibition of PKC activity via small molecule kinase inhibitors (competitive, often ATP-site binding) Activation or modulation via phorbol esters (mimic DAG, activate PKC) Isoform-specific regulation altering signal transduction pathways